SCHEMBL29426552

SCHEMBL29426552

O=c1[nH]nc(C(F)(F)F)c2cc(Br)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 3/20 0.43
WDR77 Q9BQA1 3/20 0.43
DYRK1A Q13627 3/20 0.40
JAK2 O60674 3/20 0.39
CHEK1 O14757 3/20 0.39
PIM1 P11309 2/20 0.39
FLT3 P36888 2/20 0.39
METAP2 P50579 1/20 0.39
AURKA O14965 1/20 0.39
DAPK3 O43293 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
PAK4 O96013 1/20 0.39
ABL1 P00519 1/20 0.39
NTRK1 P04629 1/20 0.39
CSF1R P07333 1/20 0.39
RET P07949 1/20 0.39
MET P08581 1/20 0.39
PDGFRB P09619 1/20 0.39
FGFR1 P11362 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29426626 0.94 PRMT5 (0.46) PRMT5WDR77DYRK1AJAK2CHEK1
SCHEMBL23526315 0.94 PRMT5 (0.46) PRMT5WDR77DYRK1AJAK2CHEK1
SCHEMBL25141598 0.82 PRMT5 (0.40) PRMT5WDR77ARALDH1A1MAPT
SCHEMBL2671320 0.81 PDPK1 (0.58) DYRK1AJAK2FLT3METAP2PRKD3
SCHEMBL29627518 0.81 PDPK1 (0.58) DYRK1AJAK2FLT3METAP2PRKD3
SCHEMBL24692312 0.81 PRMT5 (0.41) PRMT5WDR77DYRK1AJAK2CHEK1
SCHEMBL25141683 0.78 PRMT5 (0.46) PRMT5WDR77DYRK1AJAK2CHEK1
SCHEMBL30984977 0.78 PRMT5 (0.46) PRMT5WDR77DYRK1AJAK2CHEK1
SCHEMBL2671800 0.78 PDPK1 (0.58) DYRK1AJAK2CHEK1PIM1FLT3
SCHEMBL1789192 0.78 AR (0.53) PRMT5ARALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4196125-A1 COMPOUNDS, COMPOSITIONS AND METHODS Denali Therapeutics Inc. (US) 2023-06-21 EP disclosed
CN-116261456-A Compounds, compositions, and methods 戴纳立制药公司 2023-06-13 CN disclosed
WO-2022036204-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2022-02-17 WO disclosed